We offer more than just data. We offer access to value-based environments, patients and providers to
                    amplify the quality of evidence-backed insights

We amplify the critical evidence for health products and services in value focused environments

About Us

Healthagen Outcomes offers analytical and advisory services that meet the market and clinical challenges faced by pharmaceutical, biotech, and device companies. Our services use real world data, advanced technologies, and professional know-how to illuminate therapeutic and economic value. We offer collaborative resources across Aetna to enable forward looking research into real-world outcomes and the realities of therapeutic use in genuine clinical settings.

Through us, customers gain unique insights from Aetna data and access to Aetna-affiliated institutions and resources. We leverage longitudinal health claims data from up to 23M Aetna members. The Healthagen team utilizes 800+ value-based contracts and 77 strategic partnerships with ACOs across the country—including their deep provider and patient relationships*. Our integration within Aetna opens access to professionals who tackle analytics, informatics, population health, consumer and provider engagement, and data exchange/aggregation. In short, we tap into an unmatched level of resources to uncover the evidence-based understanding critical to any therapeutic area.

*Feb 2016 ACS estimates

Our Solutions

Health Economics Research

Health Economics Research

We conduct economic and clinical evidence-based research to determine the impact of therapies and technologies in real-world healthcare settings, past, present or future. We leverage medical claim, pharmacy, and laboratory data, as well as care management interactions and patient self-assessments.

Clinical Development Services

Clinical Development Services

We provide services that validate new therapies, technologies, and care models in real world environments. Our level of strategic integration within the Aetna enterprise enables recruitment and engagement with qualified trial/study participants and investigators.

Value-Based Risk Assessments

Value-Based Risk Assessments

As the healthcare industry moves toward value-based care, we lead evidence-based research studies to provide the data and insights that inform decision-makers on risk identification, analysis, mitigation, and benchmarking.

Our Approach

Our client engagements follow a systematic process to ensure maximum value and relevance. A typical arrangement proceeds in four critical steps:

1 Scope and Quantify
  • Define and assess impacted patient population
  • Size clinical and financial opportunities
  • Establish key opportunity drivers, risk factors and metrics
2 Design and Validate
  • Set program fundamentals
  • Target opportunities as previously established
  • Leverage Aetna, client, and third party assets as needed
3 Initiate Pilot
  • Conduct program in “real world” setting as first pass
  • Employ Aetna environments and provider partners
  • Monitor outcomes
  • Prove impact
4 Scale Program
  • Establish partnered, value-based business model
  • Refine program operations
  • Replicate pilot success across multiple relationships
Our Population

Our Population

26M

Total Medical Members

13M

Self Insured Employer

5.5M

Fully Insured Commercial

1.5M

Medicare

*Aetna 10-K filing February 17, 2017

Meet the Team

Van Crocker

Van Crocker

President

Van has a 19-year career in the healthcare, technology, and management consulting. Prior to Healthagen, Van led finance and business development for AuraSense, a biotechnology company founded by world-renowned nanomedicine authority, Dr. Chad Mirkin, and funded by AbbVie Biotech Ventures and Bill Gates, among others. The company has developed a broad array of nanoparticle-based genetic therapies and diagnostic platforms, with applications in cancer and autoimmune conditions. Prior to AuraSense, Mr. Crocker was with Booz & Company, focusing on payer/provider clients.

Lou Sanquini

Lou Sanquini

Vice President Life Sciences Group
Louis’ career spans more than 20 years working in a variety of ascending positions in sales, marketing, and managed care with GlaxoSmithKline and Meda pharmaceuticals. He launched and managed eleven brands while handling provider and consumer strategy. Lou led a variety of marketing, sales, and business development teams. Prior to joining Healthagen Outcomes, he was an executive team member for a patient engagement and recruitment company, QualityHealth, where he was responsible for marketing, innovation, and business development. His work significantly contributed to the company’s growth and subsequent sale to Sharecare.
Rajesh Mehta, RPh, MS

Rajesh Mehta, RPh, MS

Senior Director of Informatics
Senior Director of Informatics Rajesh has over 15 years of experience in patient care, epidemiology, and outcomes research. Rajesh worked with ActiveHealth Management and Aetna Innovations Labs to develop and patent the technology to perform adverse events surveillance on pharmaceutical products and medical devices. Rajesh was Director within the Clinical Programs and Product Development at ActiveHealth where he ran product development. Prior to ActiveHealth Management, Rajesh trained and worked as an epidemiologist under John P. Burke, MD, of Chief of Division of Clinical Epidemiology and Infectious Diseases, University of Utah.
Shawn Edmonds

Shawn Edmonds

Vice President Operations and Strategy
Vice President Operations and Strategy Shawn has been at Aetna since 1998. He has more than 22 years of experience in healthcare and has held a number of strategic leadership roles that span from Consumer Business to National Business including roles in Medicare and Pharmacy. Each of these roles focused on strategically important business transformation efforts. Just prior to joining the Healthagen Outcomes team, Shawn led the development, negotiation, and ultimately the multi-year implementation of the Medicare portion of the Pharmacy Benefit Management agreement with CVS Health. Shawn obtained a BS degree in Business Administration from Rider University and an MBA in Finance from Rutgers University.

Ready to learn more about Healthagen?